Infectious Disease Alert – May 1, 2020
May 1, 2020
View Archives Issues
In China, children of all ages have been infected with SARS-CoV-2 and seem to follow a relatively mild clinical course.
In a retrospective study of American military women involving 50 treated with atovaquone-proguanil and 156 exposed to mefloquine, no increase in risk of fetal loss or adverse infant outcomes was identified. Atovaquone-proguanil seems safe for use in pregnancy, but data are limited.
Differentiating Clostridioides difficile Infection from Chronic Carriage in Patients with Diarrhea Through Host Inflammatory Markers
Investigators compared levels of inflammatory markers in patients with Clostridioides difficile infection (CDI) to those who were colonized with it. Several markers appeared to be able to distinguish true CDI, although a gold standard definition of CDI is needed.
The key change from the 2009 vancomycin guidelines is the switch from trough-based to area under the curve (AUC)-based dosing and monitoring. This article will highlight key differences between the 2009 and 2020 guidelines, limitations of the new guidelines, and implementation issues.
Masking Our Anxiety; Is it Luck or Genetics? Neurologic Infection from SARS-CoV-2